|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 10
Zeitschriftenartikel
Berling-Ernst, A.; Yahiaoui-Doktor, M.; Kiechle, M.; Engel, C.; Lammert, J.; Grill, S.; Dukatz, R.; Rhiem, K.; Baumann, F. T.; Bischoff, S. C.; Erickson, N.; Schmidt, T.; Niederberger, U.; Siniatchkin, M. und Halle, M.
(2022):
Predictors of cardiopulmonary fitness in cancer-affected and -unaffected women with a pathogenic germline variant in the genes BRCA1/2 (LIBRE-1).
In: Scientific Reports, Bd. 12, Nr. 1, 2907
Schrodi, S.; Braun, M.; Andrulat, A.; Harbeck, N.; Mahner, S.; Kiechle, M.; Klein, E.; Schnelzer, A.; Schindlbeck, C.; Bauerfeind, I.; Schubert-Fritschle, Gabriele; Nekljudova, V.; Mayr, D.; Weichert, W.; Denkert, C.; Loibl, S. und Engel, J.
(2021):
Outcome of breast cancer patients with low hormone receptor positivity. Analysis of a 15-year population-based cohort.
In: Annals of Oncology, Bd. 32, Nr. 11: S. 1410-1424
[PDF, 1MB]
Pölcher, M.; Rottmann, Miriam; Brugger, S.; Mahner, Sven; Dannecker, C.; Kiechle, M.; Brambs, C.; Grab, D.; Anthuber, C.; Koch, F. von; Schnelzer, A. und Engel, Jutta
(2019):
Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.
In: Gynecologic Oncology, Bd. 154, Nr. 1: S. 65-71
Rottmann, Miriam; Burges, A.; Mahner, S.; Anthuber, C.; Beck, T.; Grabs, D.; Schnelzer, A.; Kiechle, M.; Mayr, D.; Pölcher, M.; Schubert-Fritschle, G. und Engel, J.
(2017):
Cancer of the ovary, fallopian tube, and peritoneum. A population-based comparison of the prognostic factors and outcomes.
In: Journal of cancer research and clinical oncology
Nitz, U.; Gluz, O.; Huober, J.; Kreipe, H. H.; Kates, R. E.; Hartmann, A.; Erber, R.; Moustafa, Z.; Scholz, M.; Lisboa, B.; Mohrmann, S.; Möbus, V.; Augustin, D.; Hoffmann, G.; Weiss, E.; Böhmer, S.; Kreienberg, R.; Bois, A. du; Sattler, D.; Thomssen, C.; Kiechle, M.; Jänicke, F.; Wallwiener, D.; Harbeck, N. und Kuhn, W.
(2017):
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014).
In: Annals of Oncology, Bd. 28, Nr. 11: S. 2899
Dam, P. A. van; Tomatis, M.; Marotti, L.; Heil, J.; Mansel, R. E.; Turco, M. Rosselli del; Dam, P. J. van; Casella, D.; Bassani, L. G.; Danei, M.; Denk, A.; Egle, D.; Emons, G.; Friedrichs, K.; Harbeck, N.; Kiechle, M.; Kimmig, R.; Köhler, U.; Kümmel, S.; Maass, N.; Mayr, C.; Prove, A.; Rageth, C.; Regolo, L.; Lorenz-Salehi, F.; Sarlos, D.; Singer, C.; Sohn, C.; Staelens, G.; Tinterri, C.; Audisio, R. und Ponti, A.
(2017):
Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
In: European Journal of Cancer, Bd. 85: S. 15-22
Rottmann, Miriam; Beck, T.; Burges, A.; Dannecker, C.; Kiechle, M.; Mayr, D.; Schlesinger-Raab, Anne; Schubert-Fritschle, Gabriele und Engel, Jutta
(2016):
Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998-2013): a population-based analysis.
In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 6: S. 1331-1341
Schwentner, L.; Harbeck, N.; Singer, S.; Eichler, M.; Rack, B.; Forstbauer, H.; Wischnik, A.; Scholz, C.; Fink, V.; Huober, J.; Fried, T.; Weissenbacher, T.; Härtl, K.; Kiechle, M. und Janni, W.
(2016):
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer Results from the prospective multi-center randomized Adebar trial.
In: Cancer Research, Bd. 76
Janni, W.; Harbeck, N.; Rack, B.; Augustin, D.; Jückstock, J.; Wischnik, A.; Annecke, K.; Scholz, C.; Huober, J.; Zwingers, T.; Friedl, T. W. P. und Kiechle, M.
(2016):
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study.
In: British Journal of Cancer, Bd. 114, Nr. 8: S. 863-871
Gluz, O.; Liedtke, C.; Huober, J.; Peyro-Saint-Paul, H.; Kates, R. E.; Kreipe, H. H.; Hartmann, A.; Pelz, E.; Erber, R.; Mohrmann, S.; Möbus, V.; Augustin, D.; Hoffmann, G.; Thomssen, C.; Jänicke, F.; Kiechle, M.; Wallwiener, D.; Kuhn, W.; Nitz, U. und Harbeck, N.
(2016):
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2-early breast cancer: WSG-AGO EC-Doc Trial.
In: Annals of Oncology, Bd. 27, Nr. 6: S. 1035-1040